Close
MyNorthwest
News
Opinion
Sports
Tools
Connect

Allergan, Teva to pay $54M in San Francisco opioid lawsuit

FILE - Trucks drive in front of Teva Pharmaceutical Logistic Center in the town of Shoam, Israel, on Oct. 16, 2013. Opioid makers Allergan and Teva have agreed to pay $54 million in cash and overdose reversal drugs to settle a federal lawsuit brought by San Francisco, in an agreement announced Tuesday, July 12, 2022. The city alleges the drug industry fueled an overdose and addiction surge in San Francisco that created a public nuisance. (AP Photo/Dan Balilty, File) FILE - The Allergan logo appears above a trading post on the floor of the New York Stock Exchange on Nov. 23, 2015. Opioid makers Allergan and Teva have agreed to pay $54 million in cash and overdose reversal drugs to settle a federal lawsuit brought by San Francisco, in an agreement announced Tuesday, July 12, 2022. The city alleges the drug industry fueled an overdose and addiction surge in San Francisco that created a public nuisance. (AP Photo/Richard Drew, File) FILE - San Francisco City Attorney David Chiu, right, stands next to Mayor London Breed, left, and former City Attorney Dennis Herrera as he speaks during a news conference on Sept. 29, 2021, in San Francisco. Opioid makers Allergan and Teva have agreed to pay $54 million in cash and overdose reversal drugs to settle a federal lawsuit brought by San Francisco. The city alleges the drug industry fueled an overdose and addiction surge in San Francisco that created a public nuisance. (Lea Suzuki/San Francisco Chronicle via AP, File)
Allergan, Teva to pay $54M in San Francisco opioid lawsuit